The fact that their groundbreaking paper 1 was published in a cancer journal (the British Journal of Cancer in 1972) set the scene for what followed on the role of apoptosis in cancer biology.

Nanjing Reju Therapeutics Inc. has described tumor necrosis factor receptor type 1-associated DEATH domain protein (TRADD) inhibitors reported to be useful for the treatment of inflammatory-related ...